Reconstituted Botulinum Toxin Type A Does Not Lose Potency in Humans If It Is Refrozen or Refrigerated for 2 Weeks Before Use
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 48 (1) , 249-253
- https://doi.org/10.1212/wnl.48.1.249
Abstract
Botulinum toxin type A (BTX-A) (Botox, Allergan, Irvine, CA) labeling recommends its use within 4 hours of reconstitution. Since BTX-A is available only in 100-unit vials, a substantial quantity is often discarded. Using eight volunteers, we measured the percent decline in extensor digitorum brevis (EDB) M-wave amplitude (percent paralysis) following injection of freshly reconstituted BTX (right EDB) and compared this with the decline following injection of BTX that was refrozen (-20 degrees C) or refrigerated (+4 degrees C) for 2 weeks (left EDB) after reconstitution. When analyzed as paired data, there was essentially no difference in the muscle paralysis resulting from fresh BTX compared with refrozen or refrigerated BTX, and no statistical difference between groups was noted. Reconstituted BTX-A that is subsequently refrigerated or refrozen for 2 weeks does not lose potency in humans. NEUROLOGY 1997;48: 249-253Keywords
This publication has 5 references indexed in Scilit:
- Dose‐response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type ANeurology, 1996
- A new look and feelNeurology, 1996
- An Algorithm for the Management of Acoustic Neuromas regarding Age, Hearing, Tumor Size, and SymptomsOtolaryngology -- Head and Neck Surgery, 1993
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- The effect of lumbar sympathectomy on fiber composition, contractility of skeletal muscle and regulation of central circulation in dogsActa Physiologica Scandinavica, 1983